Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in clinical trials to cut the risk of death by more than 40%. The trial results ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Among patients who died 2 years after TAVR, about 20% ...
"Death is pushed to one side and hidden like some embarrassing family secret. It is only by staring Death in the face that you can truly say you have known Life; it is only by losing that which you ...
The death rate among these patients is about 15 percent, researchers reported. The virus should be added to the list of opportunistic infections seen in patients with advanced H.I.V., scientists said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results